Last reviewed · How we verify
AN0025
At a glance
| Generic name | AN0025 |
|---|---|
| Also known as | E7046, Paclitaxel, Carboplatin, Radiotherapy, Platinum-based chemotherapy |
| Sponsor | Adlai Nortye Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors (PHASE1)
- A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants (PHASE1)
- AN0025 and Chemoradiotherapy Combination in Esophageal Cancer (PHASE1)
- AN0025 and Pembrolizumab Combination in Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |